Alembic Pharmaceuticals receives approval for Darifenacin ER Tablets
From USFDA
Alembic Pharmaceuticals has received USFDA approval for Darifenacin Extended-Release Tablets, 7.5 mg and 15 mg. Darifenacin Extended-Release Tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Dec 12 2017 | 11:07 AM IST